Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hany Zayed

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|June 23, 2021
Treatment of Aortoiliac Occlusive Disease With the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique: Results of a UK Multicenter StudyAthanasios Saratzis, Murtaza Salem, Cezar Sabbagh, et al.
Journal of Critical Care|June 27, 2021
Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemicManish D Sinha, Prakash Saha, Nabil Melhem, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 29, 2025
Adjunct medical therapy and its impact on survival and reintervention rates in patients with common femoral artery disease undergoing endovascular revascularization or open repairSolon Antoniades, Konstantinos P Donas, Jason T Lee, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 28, 2024
Editor's Choice - Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-2 Trial: Analysis of the Timing and Causes of Death in Participants Randomised to an Infrapopliteal Vein Bypass or Best Endovascular Treatment First Revascularisation StrategyAndrew W Bradbury, Jack Hall, Catherine A Moakes, et al.
American Journal of Hematology|April 27, 2018
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trialsJames Bussel, Donald M Arnold, Elliot Grossbard, et al.
BMJ Open|October 8, 2025
Assessing the clinical and cost-effectiveness of endovascular vs open revascularisation in severe occlusive aorto-iliac disease (EVOCC trial): study protocol for a randomised controlled trialAthanasios Saratzis, Alun Davies, Athanasios Diamantopoulos, et al.
Lancet (London, England)|April 28, 2023
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trialAndrew W Bradbury, Catherine A Moakes, Matthew Popplewell, et al.
Journal of Vascular Surgery|July 6, 2026
The United Kingdom Branch Endoprosthesis for Aortic arch Treatment study (UK-BEAT): Early experience with the GORE TAG thoracic branch endoprosthesisNoor Hamo, Ahmed Morshed, Tara Mastracci, et al.
The Lancet. Oncology|December 10, 2016
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 studyCharles M Rudin, M Catherine Pietanza, Todd M Bauer, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|June 23, 2021
Treatment of Aortoiliac Occlusive Disease With the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique: Results of a UK Multicenter StudyAthanasios Saratzis, Murtaza Salem, Cezar Sabbagh, et al.
Journal of Critical Care|June 27, 2021
Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemicManish D Sinha, Prakash Saha, Nabil Melhem, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 29, 2025
Adjunct medical therapy and its impact on survival and reintervention rates in patients with common femoral artery disease undergoing endovascular revascularization or open repairSolon Antoniades, Konstantinos P Donas, Jason T Lee, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 28, 2024
Editor's Choice - Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-2 Trial: Analysis of the Timing and Causes of Death in Participants Randomised to an Infrapopliteal Vein Bypass or Best Endovascular Treatment First Revascularisation StrategyAndrew W Bradbury, Jack Hall, Catherine A Moakes, et al.
American Journal of Hematology|April 27, 2018
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trialsJames Bussel, Donald M Arnold, Elliot Grossbard, et al.
BMJ Open|October 8, 2025
Assessing the clinical and cost-effectiveness of endovascular vs open revascularisation in severe occlusive aorto-iliac disease (EVOCC trial): study protocol for a randomised controlled trialAthanasios Saratzis, Alun Davies, Athanasios Diamantopoulos, et al.
Lancet (London, England)|April 28, 2023
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trialAndrew W Bradbury, Catherine A Moakes, Matthew Popplewell, et al.
Journal of Vascular Surgery|July 6, 2026
The United Kingdom Branch Endoprosthesis for Aortic arch Treatment study (UK-BEAT): Early experience with the GORE TAG thoracic branch endoprosthesisNoor Hamo, Ahmed Morshed, Tara Mastracci, et al.
The Lancet. Oncology|December 10, 2016
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 studyCharles M Rudin, M Catherine Pietanza, Todd M Bauer, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Pageof 9